ClinicalTrialsFinder

Primacy Immune Thrombocytopenia Clinical Trials in Suzhou, Jiangsu

1 recruitingSuzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University30 enrolled1 locationNCT07206823